McClelland R N, Horton J W
Ann Surg. 1978 Oct;188(4):439-47.
Seventeen patients with acute, persistent postvagotomy atony after vagotomy with antrectomy or pyrloroplasty for peptic ulcer underwent a doubleblind study of the relief of postvagotomy atony by metoclopramide. All patients had complete, functional gastric obstruction for at least three weeks postoperatively, precluding oral alimentation. Contrast studies and gastroscopy ruled out mechanical obstruction in each patient. Gastric outlet obstruction was confirmed by radioisotope assessment of gastric emptying of a special solid meal labeled with Technetium 99m DTPA. A gamma camera over the epigastrium precisely quantitated the emptying rate of the labeled meals. After baseline scanning an intravenous placebo was given to each patient and all 17 showed gastric retention of the meal after 90 minutes. Gastric emptying rates were restudied 24 hours later after intravenous metoclopramide and all 17 patients then immediately emptied the labeled meals. These patients then received standard postgastrectomy diets. Eight patients received metoclopramide tablets (10 mg 30 minutes a.c., q.i.d.) and nine received placebo tablets. Each of the eight patients receiving metoclopramide ate normally immediately after treatment with no further evidence of gastric atony. The nine patients receiving the placebo were unable to retain any oral feedings and were then given oral metoclopramide which promptly relieved gastric atony. All 17 patients received metoclopramide for one month without side effects after which the drug was discontinued with no recurrence of gastric symptoms during follow-up periods ranging from three to 27 months. Metoclopramide safely and effectively relieves acute, nonmechanical gastric atony when this occurs after surgical treatment of peptic ulcer.
17例因消化性溃疡行迷走神经切断术加胃窦切除术或幽门成形术后出现急性、持续性迷走神经切断术后无张力的患者,接受了甲氧氯普胺缓解迷走神经切断术后无张力的双盲研究。所有患者术后至少3周存在完全性功能性胃梗阻,无法经口进食。造影检查和胃镜检查排除了每位患者的机械性梗阻。通过用锝99m二乙三胺五乙酸标记的特殊固体餐进行胃排空的放射性同位素评估,证实了胃出口梗阻。上腹部的γ相机精确地定量了标记餐的排空率。在进行基线扫描后,给每位患者静脉注射安慰剂,90分钟后所有17例患者均出现餐食胃潴留。24小时后静脉注射甲氧氯普胺后重新研究胃排空率,所有17例患者随后立即排空了标记餐。这些患者随后接受标准的胃切除术后饮食。8例患者服用甲氧氯普胺片(餐前30分钟10毫克,每日4次),9例患者服用安慰剂片。接受甲氧氯普胺治疗的8例患者中,每例患者治疗后立即能正常进食,无进一步的胃无张力证据。接受安慰剂的9例患者无法保留任何经口喂养食物,随后给予口服甲氧氯普胺,迅速缓解了胃无张力。所有17例患者服用甲氧氯普胺1个月,无副作用,之后停药,在3至27个月的随访期内无胃症状复发。当消化性溃疡手术治疗后出现急性、非机械性胃无张力时,甲氧氯普胺能安全有效地缓解。